These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 6616963)
1. Evaluation of the natural killer cell-interferon system in patients with mid-gut carcinoid tumours treated with leucocyte interferon. Funa K; Alm GV; Rönnblom L; Oberg K Clin Exp Immunol; 1983 Sep; 53(3):716-24. PubMed ID: 6616963 [TBL] [Abstract][Full Text] [Related]
2. Inverse relationship between interferon production by mononuclear leucocytes and oxidative metabolism of neutrophil granulocytes in infection prone children. Bondestam M; Funa K; Venge P; Alm GV Clin Exp Immunol; 1985 Apr; 60(1):196-202. PubMed ID: 2408797 [TBL] [Abstract][Full Text] [Related]
3. Association of human leucocyte low responsiveness to inducers of interferon alpha with HLA-DR 2. Abb J; Zander H; Abb H; Albert E; Deinhardt F Immunology; 1983 Jun; 49(2):239-44. PubMed ID: 6406360 [TBL] [Abstract][Full Text] [Related]
4. Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon. Lotzová E; Savary CA; Quesada JR; Gutterman JU; Hersh EM J Natl Cancer Inst; 1983 Nov; 71(5):903-10. PubMed ID: 6580490 [TBL] [Abstract][Full Text] [Related]
5. Natural killer cells and interferon responses in patients with systemic lupus erythematosus. Tsokos GC; Rook AH; Djeu JY; Balow JE Clin Exp Immunol; 1982 Nov; 50(2):239-45. PubMed ID: 6817954 [TBL] [Abstract][Full Text] [Related]
6. Interferon and natural killer cells in systemic lupus erythematosus. Strannegård O; Hermodsson S; Westberg G Clin Exp Immunol; 1982 Nov; 50(2):246-52. PubMed ID: 6185256 [TBL] [Abstract][Full Text] [Related]
7. Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndrome. Hersh EM; Gutterman JU; Spector S; Friedman H; Greenberg SB; Reuben JM; LaPushin R; Matza M; Mansell PW Cancer Res; 1985 Jan; 45(1):406-10. PubMed ID: 2578099 [TBL] [Abstract][Full Text] [Related]
8. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome. Oberg K; Funa K; Alm G N Engl J Med; 1983 Jul; 309(3):129-33. PubMed ID: 6191217 [TBL] [Abstract][Full Text] [Related]
9. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines. Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754 [TBL] [Abstract][Full Text] [Related]
10. [Comparative studies of human natural IFN-alpha, IFN-beta and IFN-gamma with regard to their effects on in vitro immune responses]. Aoki N; Ohno Y; Imamura M; Matsumoto H Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1314-21. PubMed ID: 3089170 [TBL] [Abstract][Full Text] [Related]
11. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity. Edwards BS; Hawkins MJ; Borden EC Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292 [TBL] [Abstract][Full Text] [Related]
12. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha. Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406 [TBL] [Abstract][Full Text] [Related]
13. In vivo priming effects of interferon-beta ser on NK activity of peripheral blood mononuclear cells in cancer patients. Fujimiya Y; Wagner RJ; Groveman S; Sielaff K; Kohsaka T; Nakayama M Ther Immunol; 1995 Feb; 2(1):15-22. PubMed ID: 7553067 [TBL] [Abstract][Full Text] [Related]
14. Suppression of natural killer cell cytotoxicity in the peripheral blood of patients receiving interferon therapy. Spina CA; Fahey JL; Durkos-Smith D; Dorey F; Sarna G J Biol Response Mod; 1983; 2(5):458-69. PubMed ID: 6644350 [TBL] [Abstract][Full Text] [Related]
15. Correlation between in vitro and systemic effects of native and recombinant interferons-alpha on human natural killer cell cytotoxicity. Edwards BS; Hawkins MJ; Borden EC J Biol Response Mod; 1983; 2(5):409-17. PubMed ID: 6644345 [TBL] [Abstract][Full Text] [Related]
16. Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: relationship with liver disease and ethanol intake. Laso FJ; Lapeña P; Madruga JI; San Miguel JF; Orfao A; Iglesias MC; Alvarez-Mon M Alcohol Clin Exp Res; 1997 Oct; 21(7):1226-31. PubMed ID: 9347083 [TBL] [Abstract][Full Text] [Related]
17. Natural killer cytotoxic factor induction by K562 cells in patients with advanced cancer: correlation with production of interferon. Steinhauer EH; Doyle AT; Reed J; Kadish AS J Natl Cancer Inst; 1985 Dec; 75(6):1017-23. PubMed ID: 2415742 [TBL] [Abstract][Full Text] [Related]
18. Interferon treatment in patients with malignant carcinoids. Nobin A; Lindblom A; Månsson B; Sundberg M Acta Oncol; 1989; 28(3):445-9. PubMed ID: 2742782 [TBL] [Abstract][Full Text] [Related]
19. Regulation of human natural killer cell cytotoxicity by recombinant leukocyte interferon clone A. Lotzová E; Savary CA; Gutterman JU; Quesada JR; Hersh EM J Biol Response Mod; 1983; 2(5):482-96. PubMed ID: 6644351 [TBL] [Abstract][Full Text] [Related]
20. Natural killer cell function and modulation by alpha IFN and IL2 in AIDS patients and prodromal subjects. Lew F; Tsang P; Solomon S; Selikoff IJ; Bekesi JG J Clin Lab Immunol; 1984 Jul; 14(3):115-21. PubMed ID: 6237206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]